The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.
Abstract
Myocardial infarction is the most frequent cause of mortality in the United States as well as in most western countries. In this review, the processes leading to myocardial infarction are described based on the most recent studies of vascular biology; in addition, evolving strategies for prevention are outlined. The following was specifically discussed. (1) Five phases of the progression of coronary atherosclerosis (phases 1 to 5) and eight morphologically different lesions (types I, II, III, IV, Va, Vb, Vc, and VI) in the various phases are defined. (2) The present understanding of the pathogenesis of each of the phases of progression and of the various lesion types preceding myocardial infarction is described; particular emphasis is placed on the physical, structural, cellular, and chemical characteristics of the "vulnerable or unstable plaques" prone to disruption (types IV and Va lesions). (3) The fate of plaque disruption (type VI lesion) in the genesis of the various coronary syndromes and especially acute myocardial infarction is defined; particular emphasis is placed on the combination of plaque disruption and a high thrombogenic risk profile--local factors (ie, degree of plaque disruption, exposure of lipid-macrophage-rich plaque, etc) and systemic factors (ie, catecholamines, RAS, fibrinogen, etc)--in the genesis of myocardial infarction. (4) Strategies of regression or stabilization of "vulnerable or unstable plaques" for prevention of myocardial infarction are presented within the context of recent favorable experience with risk factor modification and lipid-modifying angiographic trials, beta-blockade and angiotensin-converting enzyme inhibition, antithrombotic strategies, and the possible role of estrogens. The recent past has been very fruitful in yielding a better understanding of the processes leading to myocardial infarction, and the near future appears very promising in terms of preventing the number 1 killer in the western world.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, therapies for lowering the concentration of homocysteine through vitamin supplementation did not result in the suppression of events292, 293).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [293]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y. I., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,716
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,786
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimón, L., Badimón, L., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,792
Self-citation(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,593
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 848
Nakamura, A., Monma, Y., Kajitani, S., Kozu, K., Ikeda, S., Noda, K., Nakajima, S., Endo, H., Takahashi, T., & Nozaki, E. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.02.005 · Cited by 19
Zhao, Q., Zhao, X., Feng, T., Zhang, M., Zhuang, X.-C., Xue-cheng, Z., Li, L.-Q., Li, D., & Liu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061140 · Cited by 19
Marques, J. S., & Pinto, F. J. (2014) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2013.07.017 · Cited by 20
Boden, W. E., Shah, P. K., Gupta, V., & Ohman, E. M. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.11.003 · Cited by 20
Stefanadis, C., Vavuranakis, M., & TOUTOUZAS, P. K. (2003) · Journal of Interventional Cardiology · doi:10.1034/j.1600-0854.2003.8043.x · Cited by 19
Hasebe, N., Shinsuke, K. I. D. O., Ido, A., & Kikuchi, K. (2002) · Hypertension Research · doi:10.1291/hypres.25.381 · Cited by 19
Bittner, V., Olson, M. B., Kelsey, S. F., Rogers, W. J., Merz, C. N. B., Armstrong, K., Reís, S. E., Boyette, A. F., & Sopko, G. S. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00700-1 · Cited by 19
Anzai, H., Yoneyama, S., Tsukagoshi, M., Miyake, T., Kikuchi, T., & Sakurada, M. (2003) · Circulation Journal · doi:10.1253/circj.67.768 · Cited by 19
Tyczyński, P., Pręgowski, J., Mintz, G. S., Witkowski, A., Kim, S. W., Waksman, R., Satler, L. F., Pichard, A. D., Kalińczuk, Ł., Maehara, A., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.05.022 · Cited by 19
Simultaneous measurement of blood flow and arterial wall vibrations in radial and axial directions
Sunagawa, K., Kanai, H., & Tanaka, M. (2002) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2000.921617 · Cited by 18
Avcı, B. Ş., Avcı, A., Dönmez, Y., Kaya, A., Gülen, M., Özer, A. İ., Bulut, A., Koç, M., Nazik, H., & Satar, S. (2020) · Emergency Medicine International · doi:10.1155/2020/8718304 · Cited by 18
Chaichana, T., Sun, Z., & Jewkes, J. W. (2012) · Australasian Physical & Engineering Sciences in Medicine · doi:10.1007/s13246-012-0135-3 · Cited by 18
Wang, X., Jin, P., Zhou, T., Zhao, Y., Ding, Q.-L., Wang, D., Zhao, G., Jing-Dai, Wang, H., & Ge, H. (2009) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029608330470 · Cited by 18
Progress in the Treatment of Acute Coronary Syndromes
Théroux, P., Willerson, J. T., & Armstrong, P. W. (2000) · Circulation · doi:10.1161/01.cir.102.suppl_4.iv-2 · Cited by 18
White, H. D., French, J. K., & Ellis, C. J. (1998) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1998.tb02111.x · Cited by 18
Abrams, J., Coultas, D., Malhotra, D. K., Vela, B. S., Samaan, S. A., & Roche, R. J. (1995) · Current Problems in Cardiology · doi:10.1016/s0146-2806(06)80023-x · Cited by 18
Myokardinfarkte in der Schwangerschaft
Kulka, P. J., Scheu, C., Tryba, M., Grünewald, R., Wiebalck, A., & Oberheiden, R. (2001) · Der Anaesthesist · doi:10.1007/s001010051003 · Cited by 18
Therapeutic potential of complement inhibitors in myocardial ischaemia
Tanhehco, E. J., & Lucchesi, B. R. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.5.975 · Cited by 18
Effect of leukocytosis at initial examination on prognosis in patients with primary unstable angina
Lloyd‐Jones, D. M., Camargo, C. A., Giugliano, R. P., & O’Donnell, C. J. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90019-x · Cited by 17
Lu, Y., Hsu, C., Yu, T., Wang, C.-P., Lu, L.-F., Hung, W., Chiu, C., Chung, F., Lee, Y., & Tsai, I. (2013) · Iranian Journal of Kidney Diseases · Cited by 17
Pathogenesis of Atherosclerosis
Viles-González, J. F., Badimón, J. J., & Fuster, V. (2006) · Developments in cardiovascular medicine · doi:10.1007/0-387-29553-4_3 · Cited by 18
Self-citationLi, S., Ning, H., Ye, Y., Wei, W., Guo, R., Song, Q., Liu, L., Liu, Y., Na, L., Niu, Y., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.06.001 · Cited by 17
Hemodynamic impacts of left coronary stenosis: A patient-specific analysis
Chaichana, T., Sun, Z., & Jewkes, J. W. (2013) · PubMed · doi:10.5277/abb130313 · Cited by 17
Risk Stratification in Acute Coronary Syndrome Using Cardiac Troponin I
Ravkilde, J. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.4.443 · Cited by 17
The use of electron-beam computed tomography as a tool for primary prevention
Raggi, P. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01880-x · Cited by 17
Faber, L., Seggewiß, H., Ziemssen, P., & Gleichmann, U. (1999) · Catheterization and Cardiovascular Interventions · doi:10.1002/(sici)1522-726x(199908)47:4 · Cited by 59
Vuong, T. N. A. M., Bartolf‐Kopp, M., Andelovic, K., Jüngst, T., Farbehi, N., Wise, S. G., Hayward, C., Stevens, M. C., & Rnjak‐Kovacina, J. (2024) · Advanced Science · doi:10.1002/advs.202307627 · Cited by 17
Centurión, O. A. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010135 · Cited by 16
L-arginine: a novel therapy for coronary artery disease?
Velianou, J. L., Suwaidi, J. M. S. A., & Lerman, A. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.11.1785 · Cited by 16
Molecular and Nonmolecular Magnetic Resonance Coronary and Carotid Imaging
Hajhosseiny, R., Bahaei, T. S., Prieto, C., & Botnar, R. M. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311754 · Cited by 16
Rosenberg, N., Zivelin, A., Chetrit, A., Dardik, R., Kornbrot, N., Freimark, D., & Inbal, A. (2002) · PubMed · Cited by 16
CORRELATION OF MECHANICAL BEHAVIOR AND MMP-1 PRESENCE IN HUMAN ATHEROSCLEROTIC PLAQUE
Kilpatrick, D. L., Xu, C., Vito, R. P., & Glagov, S. (2002) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519402000137 · Cited by 16
Chen, L., Hung, K.-H., Tseng, Y., Wang, H., Lu, T., Huang, W., & Tsao, Y. (2023) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2023.3307794 · Cited by 21
Yamagishi, T., Katô, M., Koiwa, Y., Hasegawa, H., & Kanai, H. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.760 · Cited by 15
Cardiovascular Disease Risk Factors Other than Dyslipidemia
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17368 · Cited by 16
Plaque instability in peripheral vessels
Silva, J. A., & White, C. J. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.123472 · Cited by 15
Patient specific 3-d modeling of blood flow in a multi-stenosed left coronary artery
Kamangar, S., Badruddin, I. A., Ahammad, N. A., Soudagar, M. E. M., Govindaraju, K., Ghazali, N. N. N., Ahmed, N. J. S., & Khan, T. M. Y. (2017) · Bio-Medical Materials and Engineering · doi:10.3233/bme-171672 · Cited by 15
Comparison of outcomes in ST-elevation myocardial infarction according to age
Zgheib, H., Souky, N. A., Majzoub, I. E., Wakil, C., Sweidan, K., Kaddoura, R., Hariri, M. A., & Chebel, R. B. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.05.023 · Cited by 15
Effect of Family History of Type 2 Diabetes on White Blood Cell Count in Adult Women
Pannacciulli, N., Giorgino, F., Martina, R. A., Resta, O., GIORGINO, R., & Pergola, G. D. (2003) · Obesity Research · doi:10.1038/oby.2003.169 · Cited by 15
Roitman, J. L., LaFontaine, T., & Drimmer, A. M. (1998) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199803000-00004 · Cited by 15
Coronary Artery Calcium in HIV-infected Men Treated With Highly Active Antiretroviral Therapy
Robinson, F. P., Hoff, J. A., & Kondos, G. T. (2005) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200505000-00005 · Cited by 15
Organosulfur Compounds from Garlic
Holub, B. J., Nagpurkar, A., Arnott, K. L., Davis, J.-P., & Peschell, J. (2002) · Functional foods & nutraceuticals series · doi:10.1201/9781420012873.ch7 · Cited by 15
Age-Related Changes in Blood Coagulation and Fibrinolysis in Mice Fed on a High-Cholesterol Diet.
Okazaki, M., Morio, Y., Iwai, S., MIYAMOTO, K.-I., Sakamoto, H., Imai, K., & Oguchi, K. (1998) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.47.237 · Cited by 15
Endothelial Function: Strategies for Early Intervention
Verhaar, M. C., & Rabelink, T. J. (1998) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007737412395 · Cited by 15
Homocysteinylation of Metallothionein Impairs Intracellular Redox Homeostasis
Colgan, S. M., & Austin, R. C. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000254151.00086.26 · Cited by 15
Inflamación e infección en la enfermedad coronaria estable y en el síndrome coronario agudo
García, J. B., Martínez, P. M., Rodríguez, J. F. M., Carpente, M. M. D. L. T., Bustamante, R. B., Peral, A. B. G., de Lejarazu, R. O., Bouza, J. M. E., García, S. B., & y, F. F.-A. (2001) · Revista Española de Cardiología · doi:10.1016/s0300-8932(01)76333-6 · Cited by 14
Scherer, D. J., & Psaltis, P. J. (2016) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2015.12.02 · Cited by 14
Mousa, S. A., Abulencia, J. P., McCarty, O. J. T., Turner, N. A., & Κωνσταντόπουλος, Κ. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200204000-00011 · Cited by 14
Pothula, A., Serebruany, V. L., Gurbel, P., McKenzie, M. E., & Atar, D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00440-4 · Cited by 14
The amount of fibrinogen-positive platelets predicts the occurrence of in-stent restenosis
Jaster, M., Horstkotte, D., Willich, T., Stellbaum, C., Knie, W., Spencker, S., Pauschinger, M., Schultheiß, H., & Rauch, U. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.020 · Cited by 14
Takazoe, K., Ogawa, H., Yasue, H., Sakamoto, T., Oshima, S., Arai, H., Moriyama, Y., Shimomura, H., Hirai, N., Kaikita, K., et al. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00020-1 · Cited by 14
Early and late mortality after surgery for unstable angina in relation to Braunwald class
Bjessmo, S., Ivert, T., Flink, H., & Hammar, N. (2001) · American Heart Journal · doi:10.1067/mhj.2001.111955 · Cited by 14
Patients at High Risk for Ischemic Stroke: Identification and Actions
Gállego, J., Martínez‐Vila, E., & Muñóz, R. (2007) · Cerebrovascular Diseases · doi:10.1159/000107379 · Cited by 14
Ingster, L. M., & Feinleib, M. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.9.1554 · Cited by 14
Jaeger, B. R., Marx, P., Pfefferkorn, T., Hamann, G. F., & Seidel, D. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6391-7_13 · Cited by 14
Noninvasive Thrombolysis Using Histotripsy Pulsed Ultrasound Cavitation Therapy.
Maxwell, A. D. (2012) · Deep Blue (University of Michigan) · Cited by 14
Patil, C. V., & Beyar, R. (2000) · International Journal of Cardiovascular Interventions · doi:10.1080/14628840050515948 · Cited by 13
Rodríguez-Flores, M., Rodríguez‐Saldaña, J., Cantú-Brito, C. G., Aguirre‐García, J., & Garay, A. G. G. (2013) · Cardiovascular Pathology · doi:10.1016/j.carpath.2013.01.008 · Cited by 13
Noninvasive imaging modalities to visualize atherosclerotic plaques
Shishikura, D. (2016) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2015.11.07 · Cited by 13
The Role of Clopidogrel in the Management of Patients with Ischemic Heart Disease
Chopra, V., Marmur, J. D., & Çavuşoğlu, E. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/b:card.0000015862.62649.c8 · Cited by 13
Development of polymeric drug delivery system for recognizing vascular endothelial dysfunction
Ikuta, K., Mori, T., Yamamoto, T., Niidome, T., Shimokawa, H., & Katayama, Y. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.01.006 · Cited by 13
Kurata, T., KURATA, M., & Okada, T. (2001) · Journal of International Medical Research · doi:10.1177/147323000102900409 · Cited by 13
DEFINITION, CLASSIFICATION, AND PATHOPHYSIOLOGY OF ACUTE CORONARY ISCHEMIC SYNDROMES
Diop, D., & Aghababian, R. V. (2001) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(05)70182-6 · Cited by 13
Kleiman, N. S., Granger, C. B., White, H. D., Armstrong, P. W., Ardissino, D., de Werf, F. V., Zoldeyhi, P., Thompson, T., Califf, R. M., & Topol, E. J. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70455-2 · Cited by 13
Smith, S. C. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00716-4 · Cited by 13
Ni, Y., Dymarkowski, S., Chen, F., Bogaert, J. G., & Marchal, G. (2002) · Radiology · doi:10.1148/radiol.2252020113 · Cited by 13
Weiss, M. B., Narasimhadevara, S. M., Feng, G. Q., & Shen, J. T. (2002) · Heart Disease · doi:10.1097/00132580-200201000-00002 · Cited by 12
Centurión, O. A. (2011) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0b013e318223e35d · Cited by 12
Nijdam, A. J., Nicholson, T. R., Shapiro, J. P., Smith, B. R., Heverhagen, J. T., Schmalbrock, P., Knopp, M. V., Kebbel, A., Wang, D., & Lee, S. (2009) · Current Nanoscience · doi:10.2174/157341309787314601 · Cited by 12
An Emerging Paradigm in Atherosclerosis: Focus on Subclinical Disease
Miller, M. J. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.03.1976 · Cited by 12
Coronary artery spatial distribution of chronic total occlusions: Insights from a large US registry
Garcia, S. A., Alraies, M. C., Karatasakis, A., Yannopoulos, D., Karmpaliotis, D., Alaswad, K., Jaffer, F. A., Yeh, R. W., Patel, M. P., Bahadorani, J. N., et al. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26844 · Cited by 12
Kanshana, J. S., Rebello, S. C., Pathak, P., Kanuri, B., Aggarwal, H., Srivastava, V., Khanna, V., Singh, V., Jagavelu, K., Barthwal, M. K., et al. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.11.004 · Cited by 12
Biondi‐Zoccai, G., Mastrangeli, S., Romagnoli, E., Peruzzi, M., Frati, G., Roever, L., & Giordano, A. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0709-y · Cited by 12
Vulnerable plaques, inflammation and newer imaging modalities.
Bhatia, V., Bhatia, R., Dhindsa, S., & Virk, A. (2003) · PubMed · Cited by 12
Coronary atherosclerosis stabilization: an achievable goal
Maher, V. M. G. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05732-3 · Cited by 12
Utsunomiya, D., Fukunaga, T., Oda, S., Awai, K., Nakaura, T., Urata, J., & Yamashita, Y. (2010) · Heart and Vessels · doi:10.1007/s00380-010-0074-4 · Cited by 12
Physiopathologie et étiopathogénie de l’infarctus du myocarde
Akoudad, H., Benamer, H., & Kamal, A. (2004) · EMC - Cardiologie · doi:10.1016/j.emcaa.2003.12.003 · Cited by 13
Vulnerable plaque paradigm: Prediction of future clinical events based on a morphological definition
Granada, J. F., Kałuża, G. L., Raizner, A. E., & Moreno, P. (2004) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.20059 · Cited by 12
Detection of myocardial ischemia
JAIN, A., & MURRAY, D. (1995) · Current Problems in Cardiology · doi:10.1016/s0146-2806(06)80019-8 · Cited by 12
Antioxidants, atherosclerosis and thrombosis
Rao, G. H. R., & Parthasarathy, S. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90011-3 · Cited by 12
Pathophysiology of Coronary Artery Disease
Fernández‐Ortíz, A., & Fuster, V. (1996) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30240-4 · Cited by 12
Self-citationLi, T., Wang, J., Xie, H., Hao, P., Qing, C., Zhang, Y., Liao, X., & Liang, T. (2020) · Dermatologic Therapy · doi:10.1111/dth.14410 · Cited by 11
Diagnosis of coronary layered plaque by deep learning
Araki, M., Park, S. J., Nakajima, A., Lee, H., Ye, J. C., & Jang, I. (2023) · Scientific Reports · doi:10.1038/s41598-023-29293-6 · Cited by 11
Khalifa, A. A., Cornily, J., David, C., Choplain, J.-N., Gal, G. L., Barra, J. A., & Bezon, E. (2011) · Cardiology · doi:10.1159/000335068 · Cited by 11
Bosanquet, N., nsson, B. J., & Fox, K. A. A. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321160-00001 · Cited by 11
Clopidogrel in the Management of Ischemic Heart Disease
Çavuşoğlu, E., Cheng, J. W. M., Bhatt, R., Kunamneni, P., Marmur, J. D., & Eng, C. (2003) · Heart Disease · doi:10.1097/01.hdx.0000061697.22030.e5 · Cited by 11
Matrix metalloproteinase-9 in spontaneously hypertensive hyperlipidemic rats
Asano, Y., Iwai, S., Okazaki, M., Kumai, T., Munemasa, Y., Oonuma, S., Tadokoro, M., Kobayashi, S., & Oguchi, K. (2008) · Pathophysiology · doi:10.1016/j.pathophys.2007.02.001 · Cited by 11
Pathogenesis of Atherosclerosis
Fernández‐Ortíz, A., Badimón, J. J., & Fuster, V. (1999) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5007-5_1 · Cited by 11
Self-citationInflammation in Acute Coronary Syndromes
Moreno, P., & Fallon, J. T. (1997) · Springer eBooks · doi:10.1007/978-3-642-60463-8_19 · Cited by 11
Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial Infarction
Roe, M. T., Giugliano, R. P., Harrington, R. A., Gibson, C. M., Strony, J. T., Kitt, M. M., Califf, R. M., & D, E. B. M. (2001) · Heart Drug · doi:10.1159/000022704 · Cited by 11
Iwai, N., Tamaki, S., Ohmichi, N., & Kinoshita, M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.9.1730 · Cited by 11
Coronary Heart Disease Syndromes: Pathophysiology and Clinical Recognition
Willerson, J. T., & Armstrong, P. W. (2015) · Cardiovascular medicine · doi:10.1007/978-1-4471-2828-1_15 · Cited by 11
Evaluation of Platelet Antagonists in In Vitro Flow Models of Thrombosis
McCarty, O. J. T., Abulencia, J. P., Mousa, S. A., & Κωνσταντόπουλος, Κ. (2004) · Humana Press eBooks · doi:10.1385/1-59259-658-4:21 · Cited by 10
Yang, Y., Li, J., Xu, W., Dong, S., Yu, H., Song, H., & Chu, Y. (2016) · Journal of International Medical Research · doi:10.1177/0300060516667373 · Cited by 10
Ernst, D., Weiberg, D., Baerlecken, N. T., Schlumberger, W., Dähnrich, C., Schmidt, R. E., Bengel, F. M., Derlin, T., & Witte, T. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.02.010 · Cited by 10
Lipid disorders contributing to coronary heart disease: An update
Superko, H. R. (1996) · Current Problems in Cardiology · doi:10.1016/s0146-2806(96)80005-3 · Cited by 10
Chen, P., Sun, C., & Liu, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500462200 · Cited by 10
Updated pathophysiologic concepts in unstable coronary artery disease
Conti, C. R. (2001) · American Heart Journal · doi:10.1067/mhj.2001.109950 · Cited by 10
Atherothrombotic plaques and the need for imaging
Fayad, Z. A., & Fuster, V. (2002) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(02)00017-5 · Cited by 10
Self-citationA Review of Electron Beam Computed Tomography: Implications for Coronary Artery Disease Screening
Redberg, R. F., & Shaw, L. J. (2002) · Preventive Cardiology · doi:10.1111/j.1520-037x.2002.0576.x · Cited by 10
Metadata
- Authors
- Fuster, V
- Affiliations
- Mount Sinai Hospital (US)
- Corresponding author
- Fuster, V
- ORCID
- Fuster, V
- Venue
- Circulation
- Published
- 1994-10
- Volume
- 90
- Issue
- 4
- Pages
- 2126-2146
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2110185147
- Cited by
- 848
- References
- 240
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 4 · 2020: 14 · 2019: 6 · 2018: 5 · 2017: 12 · 2016: 19 · 2015: 16 · 2014: 19 · 2013: 24 · 2012: 18
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- myocardial infarction, coronary artery disease, vulnerable plaque, plaque disruption, lesion type, plaque regression, thrombosis, coronary syndrome, risk factor control, lipid therapy, beta-adrenergic blockade, angiotensin-converting enzyme inhibition, antithrombotic therapy, estrogen, vascular biology
- MeSH terms
- Coronary Artery Disease, Coronary Thrombosis, Coronary Vessels, Humans, Myocardial Infarction, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review